Moving towards precision urologic oncology
Laufzeit: 01.01.2015 - 31.12.2017
imported
Kurzfassung
Projekt targeting Enzalutamide-resistant prostate cancer and mutated forms of the androgen receptor using the novel inhibitor ODM-201
